Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Brooke L Fridley
Affiliation
H. Lee Moffitt Cancer Center and Research Institute
ORCID
Career Start Year
2003
Papers
292
H Index
54
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36151773
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation.
Cancer Med
2023
37557966
The relationship of lifetime history of depression on the ovarian tumor immune microenvironment.
Brain Behav Immun
2023
37525619
Associations between prediagnostic aspirin use and ovarian tumor gene expression.
Cancer Med
2023
37407670
A harmonized resource of integrated prostate cancer clinical, -omic, and signature features.
Sci Data
2023
36940177
Measurement of Ovarian Tumor Immune Profiles by Multiplex Immunohistochemistry: Implications for Epidemiologic Studies.
Cancer Epidemiol Biomarkers Prev
2023
36761962
Predictors of residual disease after debulking surgery in advanced stage ovarian cancer.
Front Oncol
2023
36929081
Statistics and Machine Learning in Mass Spectrometry-Based Metabolomics Analysis.
Methods Mol Biol
2023
36929076
A Primer on Preprocessing, Visualization, Clustering, and Phenotyping of Barcode-Based Spatial Transcriptomics Data.
Methods Mol Biol
2023
36929074
Statistical Methods for Integrative Clustering of Multi-omics Data.
Methods Mol Biol
2023
36929070
Multi-omics Data Deconvolution and Integration: New Methods, Insights, and Translational Implications.
Methods Mol Biol
2023
36861411
<i>PARP1</i> and <i>POLD2</i> as prognostic biomarkers for multiple myeloma in autologous stem cell transplant.
Haematologica
2023
36094443
Pilot Study in Investigating Material Financial Toxicity Markers by Age in Cancer Patients.
J Adolesc Young Adult Oncol
2023
36318652
Lifetime Exposure to Cigarette Smoke and Risk of Ovarian Cancer by T-cell Tumor Immune Infiltration.
Cancer Epidemiol Biomarkers Prev
2023
33983850
Clinical Trial Availability by Location for 1000 Simulated AYA Patients.
J Adolesc Young Adult Oncol
2022
35653140
Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer.
Clin Cancer Res
2022
35562768
Lifetime ovulatory years and ovarian cancer gene expression profiles.
J Ovarian Res
2022
36018828
Prognostic features of endometrial cancer metastasis to the central nervous system.
PLoS One
2022
35319481
A Question-and-Answer System to Extract Data From Free-Text Oncological Pathology Reports (CancerBERT Network): Development Study.
J Med Internet Res
2022
35094053
Prospective Analyses of Sedentary Behavior in Relation to Risk of Ovarian Cancer.
Am J Epidemiol
2022
35244678
Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma.
Cancer Epidemiol Biomarkers Prev
2022
35032707
Mitochondrial DNA sequence variation and risk of glioma.
Mitochondrion
2022
35235563
Tumor immune cell clustering and its association with survival in African American women with ovarian cancer.
PLoS Comput Biol
2022
35234924
Summarizing internal dynamics boosts differential analysis and functional interpretation of super enhancers.
Nucleic Acids Res
2022
35258565
spatialGE: quantification and visualization of the tumor microenvironment heterogeneity using spatial transcriptomics.
Bioinformatics
2022
32926366
Statistical and Bioinformatics Analysis of Data from Bulk and Single-Cell RNA Sequencing Experiments.
Methods Mol Biol
2021
33613870
Wide and deep learning for automatic cell type identification.
Comput Struct Biotechnol J
2021
33890980
Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes.
Blood Adv
2021
34734969
spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence data.
Bioinformatics
2021
34669147
Mitochondrial DNA sequence variation and risk of meningioma.
J Neurooncol
2021
33989014
Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt Experience.
JCO Clin Cancer Inform
2021
34204319
Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data.
Cancers (Basel)
2021
33452133
The harsh microenvironment in early breast cancer selects for a Warburg phenotype.
Proc Natl Acad Sci U S A
2021
32975643
"I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.
Support Care Cancer
2021
32859560
The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes.
J Geriatr Oncol
2021
32851660
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.
Int J Cancer
2021
31199438
GMSimpute: a generalized two-step Lasso approach to impute missing values in label-free mass spectrum analysis.
Bioinformatics
2020
31999549
Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization.
Comput Biol Med
2020
31839342
Predictors of survival trajectories among women with epithelial ovarian cancer.
Gynecol Oncol
2020
31780380
Implant-sparing Mastectomy: An Alternative for Women Undergoing Mastectomy With Retropectoral Implants.
Clin Breast Cancer
2020
33117761
Ontogeny Related Changes in the Pediatric Liver Metabolome.
Front Pediatr
2020
33396385
DNA Methylation in Ovarian Cancer Susceptibility.
Cancers (Basel)
2020
32696098
Utility of Taking Additional Margins When Performing Breast-Conserving Surgery with Intraoperative Radiation Therapy for Early Breast Cancer.
World J Surg
2020
32386107
Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.
Pediatr Blood Cancer
2020
32176331
An evolutionary framework for treating pediatric sarcomas.
Cancer
2020
31437624
Statistical genomics in rare cancer.
Semin Cancer Biol
2020
31549389
Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.
Clin Pharmacol Ther
2020
31600840
Patterns and predictors of genetic referral among ovarian cancer patients at a National Cancer Institute-Comprehensive Cancer Center.
Clin Genet
2020
30548250
Lenalidomide-based response-adapted therapy for older adults without high risk myeloma.
Br J Haematol
2019
30026572
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML.
Leukemia
2019
31550266
Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines.
PLoS One
2019
1 - 50 of 292
Column Actions
Search
Recommended Authors
Shaolong Cao
the University of Texas MD Anderson Cancer Center
Career Start Year
2014
Number of shared co-authors
6
Guanglong Jiang
Indiana University School of Medicine
Career Start Year
2011
Number of shared co-authors
1
Stephen R Piccolo
Brigham Young University
Career Start Year
2008
Number of shared co-authors
2
Eunjee Lee
Chungnam National University
Career Start Year
2007
Number of shared co-authors
2
Jennifer Clarke
Department of Food Science and Technology, University of Nebraska-Lincoln
Career Start Year
2006
Number of shared co-authors
4
Kouros Owzar
Duke University
Career Start Year
2005
Number of shared co-authors
40
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year
2004
Number of shared co-authors
1
Abul Kalam Azad
University of Dhaka
Career Start Year
2004
Number of shared co-authors
2
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year
2003
Number of shared co-authors
10
Olivier Harismendy
University of California
Career Start Year
2003
Number of shared co-authors
1
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year
2002
Number of shared co-authors
25
Keyue Ding
Queen's University
Career Start Year
2002
Number of shared co-authors
9
Alison A Motsinger-Reif
National Institute of Environmental Health Sciences
Career Start Year
2002
Number of shared co-authors
18
Michael Slifker
Fox Chase Cancer Center
Career Start Year
2002
Number of shared co-authors
0
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
12
Joel A Mefford
University of California los angeles
Career Start Year
2001
Number of shared co-authors
5
Mark A van de Wiel
Amsterdam University Medical Centers (Amsterdam UMC)
Career Start Year
2001
Number of shared co-authors
8
Joshua Millstein
Keck School of Medicine, University of Southern California
Career Start Year
2001
Number of shared co-authors
96
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year
2001
Number of shared co-authors
8
George C Tseng
University of Pittsburgh School of Public Health
Career Start Year
2001
Number of shared co-authors
1
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year
2000
Number of shared co-authors
54
Celine Lefebvre
The Scripps Research Institute
Career Start Year
1999
Number of shared co-authors
0
Kerby Shedden
University of Michigan ann arbor
Career Start Year
1999
Number of shared co-authors
0
Giovanni Parmigiani
Dana Farber Cancer Institute.
Career Start Year
1997
Number of shared co-authors
26
Hongyu Zhao
Yale University
Career Start Year
1995
Number of shared co-authors
19
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year
1994
Number of shared co-authors
6
Adam B Olshen
12224University of California san francisco
Career Start Year
1993
Number of shared co-authors
7
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
4
Yudi Pawitan
Karolinska Institute
Career Start Year
1988
Number of shared co-authors
19
Paul C Boutros
University of California los angeles
Career Start Year
1970
Number of shared co-authors
40
row(s) 1 - 30 of 30
Collaborators
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers
143
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers
85
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers
76
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers
76
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers
73
Andrew Berchuck
Duke School of Medicine
Co-authored papers
67
Honglin Song
University of Cambridge
Co-authored papers
64
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers
64
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers
63
Usha Menon
College of Nursing, University of South Florida
Co-authored papers
63
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers
59
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers
59
Jonathan Tyrer
Co-authored papers
57
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers
56
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers
56
Anna H Wu
University of Southern California
Co-authored papers
56
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers
56
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers
56
Alice S Whittemore
Co-authored papers
55
Diether Lambrechts
Co-authored papers
54
Hoda Anton-Culver
University of California irvine
Co-authored papers
53
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers
53
Weiva Sieh
Co-authored papers
49
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers
46
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers
46
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers
45
Elisa V Bandera
Co-authored papers
45
Gregory D Jenkins
Mayo Clinic
Co-authored papers
43
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers
42
Louise A Brinton
National Cancer Institute
Co-authored papers
41
1 - 30